
### [MONDO:0015611](http://purl.obolibrary.org/obo/MONDO_0015611)
**Label:** neutral lipid storage disease

**Subclasses:** [MONDO:0010155](http://purl.obolibrary.org/obo/MONDO_0010155) (Dorfman-Chanarin disease), [MONDO:0012545](http://purl.obolibrary.org/obo/MONDO_0012545) (neutral lipid storage myopathy), 

**Mapped go classes:** [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0003841](http://purl.obolibrary.org/obo/GO_0003841) (1-acylglycerol-3-phosphate O-acyltransferase activity), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0044242](http://purl.obolibrary.org/obo/GO_0044242) (cellular lipid catabolic process), [GO:0032048](http://purl.obolibrary.org/obo/GO_0032048) (cardiolipin metabolic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:0071555](http://purl.obolibrary.org/obo/GO_0071555) (cell wall organization), [GO:0010898](http://purl.obolibrary.org/obo/GO_0010898) (positive regulation of triglyceride catabolic process), [GO:0051006](http://purl.obolibrary.org/obo/GO_0051006) (positive regulation of lipoprotein lipase activity), [GO:0050996](http://purl.obolibrary.org/obo/GO_0050996) (positive regulation of lipid catabolic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0010891](http://purl.obolibrary.org/obo/GO_0010891) (negative regulation of sequestering of triglyceride), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0006654](http://purl.obolibrary.org/obo/GO_0006654) (phosphatidic acid biosynthetic process), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:0004623](http://purl.obolibrary.org/obo/GO_0004623) (phospholipase A2 activity), [GO:0042171](http://purl.obolibrary.org/obo/GO_0042171) (lysophosphatidic acid acyltransferase activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0035965](http://purl.obolibrary.org/obo/GO_0035965) (cardiolipin acyl-chain remodeling), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0004806](http://purl.obolibrary.org/obo/GO_0004806) (triglyceride lipase activity), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0046473](http://purl.obolibrary.org/obo/GO_0046473) (phosphatidic acid metabolic process) 55.56%
- [GO:0035965](http://purl.obolibrary.org/obo/GO_0035965) (cardiolipin acyl-chain remodeling) 55.56%
- [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process) 55.56%
- [GO:0006654](http://purl.obolibrary.org/obo/GO_0006654) (phosphatidic acid biosynthetic process) 55.56%
- [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane) 55.56%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 55.56%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 55.56%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 55.56%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane) 55.56%
- [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process) and [GO:0046464](http://purl.obolibrary.org/obo/GO_0046464) (acylglycerol catabolic process) 55.56%
- [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process) and [GO:0046461](http://purl.obolibrary.org/obo/GO_0046461) (neutral lipid catabolic process) 55.56%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) and [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 55.56%
- Thing 51.92%
- [GO:0046471](http://purl.obolibrary.org/obo/GO_0046471) (phosphatidylglycerol metabolic process) 40.91%
- [GO:0032048](http://purl.obolibrary.org/obo/GO_0032048) (cardiolipin metabolic process) 40.91%


